1.1CLJan 30
MM-THEBench: Do Reasoning MLLMs Think Reasonably?Zhidian Huang, Zijun Yao, Ji Qi et al.
Recent advances in multimodal large language models (MLLMs) mark a shift from non-thinking models to post-trained reasoning models capable of solving complex problems through thinking. However, whether such thinking mitigates hallucinations in multimodal perception and reasoning remains unclear. Self-reflective reasoning enhances robustness but introduces additional hallucinations, and subtle perceptual errors still result in incorrect or coincidentally correct answers. Existing benchmarks primarily focus on models before the emergence of reasoning MLLMs, neglecting the internal thinking process and failing to measure the hallucinations that occur during thinking. To address these challenges, we introduce MM-THEBench, a comprehensive benchmark for assessing hallucinations of intermediate CoTs in reasoning MLLMs. MM-THEBench features a fine-grained taxonomy grounded in cognitive dimensions, diverse data with verified reasoning annotations, and a multi-level automated evaluation framework. Extensive experiments on mainstream reasoning MLLMs reveal insights into how thinking affects hallucination and reasoning capability in various multimodal tasks.
1.4LGJan 30
User-Adaptive Meta-Learning for Cold-Start Medication Recommendation with Uncertainty FilteringArya Hadizadeh Moghaddam, Mohsen Nayebi Kerdabadi, Dongjie Wang et al.
Large-scale Electronic Health Record (EHR) databases have become indispensable in supporting clinical decision-making through data-driven treatment recommendations. However, existing medication recommender methods often struggle with a user (i.e., patient) cold-start problem, where recommendations for new patients are usually unreliable due to the lack of sufficient prescription history for patient profiling. While prior studies have utilized medical knowledge graphs to connect medication concepts through pharmacological or chemical relationships, these methods primarily focus on mitigating the item cold-start issue and fall short in providing personalized recommendations that adapt to individual patient characteristics. Meta-learning has shown promise in handling new users with sparse interactions in recommender systems. However, its application to EHRs remains underexplored due to the unique sequential structure of EHR data. To tackle these challenges, we propose MetaDrug, a multi-level, uncertainty-aware meta-learning framework designed to address the patient cold-start problem in medication recommendation. MetaDrug proposes a novel two-level meta-adaptation mechanism, including self-adaptation, which adapts the model to new patients using their own medical events as support sets to capture temporal dependencies; and peer-adaptation, which adapts the model using similar visits from peer patients to enrich new patient representations. Meanwhile, to further improve meta-adaptation outcomes, we introduce an uncertainty quantification module that ranks the support visits and filters out the unrelated information for adaptation consistency. We evaluate our approach on the MIMIC-III and Acute Kidney Injury (AKI) datasets. Experimental results on both datasets demonstrate that MetaDrug consistently outperforms state-of-the-art medication recommendation methods on cold-start patients.